Literature DB >> 15759160

[Inpatient treatment of depression. Should one combine psychotherapy and drugs?].

T J Huber1.   

Abstract

Antidepressants as well as different psychotherapeutic strategies have been proven efficacious in the treatment of unipolar depression. In the clinical setting both are often combined using psychotherapeutic methods varying from psychoeducation to formal psychotherapy. The present article provides a critical overview of the evidence base for this combination in the inpatient treatment of depression. The current literature is contradictory and difficult to compare. However, combination therapy appears advantageous in therapy-resistant, chronic and severe forms of depressive disorders. Much further research is needed to facilitate well-founded guidelines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15759160     DOI: 10.1007/s00115-004-1839-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  31 in total

Review 1.  Flawed meta-analyses comparing psychotherapy with pharmacotherapy.

Authors:  D F Klein
Journal:  Am J Psychiatry       Date:  2000-08       Impact factor: 18.112

Review 2.  Integrating psychotherapy and pharmacotherapy to improve outcomes among patients with mood disorders.

Authors:  Ripu D Jindal; Michael E Thase
Journal:  Psychiatr Serv       Date:  2003-11       Impact factor: 3.084

3.  Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.

Authors:  C F Reynolds; E Frank; J M Perel; S D Imber; C Cornes; M D Miller; S Mazumdar; P R Houck; M A Dew; J A Stack; B G Pollock; D J Kupfer
Journal:  JAMA       Date:  1999-01-06       Impact factor: 56.272

4.  Combining psychotherapy and antidepressants in the treatment of depression.

Authors:  F de Jonghe; S Kool; G van Aalst; J Dekker; J Peen
Journal:  J Affect Disord       Date:  2001-05       Impact factor: 4.839

5.  Cognitive-behavioral treatment of depressed inpatients: six- and twelve-month follow-up.

Authors:  I W Miller; W H Norman; G I Keitner
Journal:  Am J Psychiatry       Date:  1989-10       Impact factor: 18.112

Review 6.  When are psychotherapy and pharmacotherapy combinations the treatment of choice for major depressive disorder?

Authors:  M E Thase
Journal:  Psychiatr Q       Date:  1999

Review 7.  Psychotherapy and pharmacotherapy: toward an integrative model.

Authors:  T B Karasu
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

Review 8.  Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990s.

Authors:  Ulrich Hegerl; Anita Plattner; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-04       Impact factor: 5.270

Review 9.  Combined pharmacotherapy and psychological treatment for depression: a systematic review.

Authors:  Sandro Pampallona; Paola Bollini; Giuseppe Tibaldi; Bruce Kupelnick; Carmine Munizza
Journal:  Arch Gen Psychiatry       Date:  2004-07

10.  Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder.

Authors:  Roy H Perlis; Andrew A Nierenberg; Jonathan E Alpert; Joel Pava; John D Matthews; Jaqueline Buchin; Andrea H Sickinger; Maurizio Fava
Journal:  J Clin Psychopharmacol       Date:  2002-10       Impact factor: 3.153

View more
  2 in total

1.  [Guideline-conform inpatient psychiatric psychotherapeutic treatment of chronic depression: Normative personnel requirements].

Authors:  K Schnell; A Hochlehnert; M Berger; J Wolff; M Radtke; E Schramm; C Normann; S C Herpertz
Journal:  Nervenarzt       Date:  2016-03       Impact factor: 1.214

2.  Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: rationale and design of a randomized controlled trial.

Authors:  Gilles Ambresin; Jean-Nicolas Despland; Martin Preisig; Yves de Roten
Journal:  BMC Psychiatry       Date:  2012-10-30       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.